Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexinidazole Dosing Regimens for Chronic Indeterminate Chagas Disease
NCT02498782Phase 2Unknown
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Jul 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fexinidazole in Chagas disease, sponsored by Drugs for Neglected Diseases initiative. Status: unknown.
02
Drugs
Fexinidazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT02498782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02498782.